Latest Breaking News On - Eccogene inc - Page 1 : comparemela.com

Astra, Pfizer boost China bets despite US drive to decouple

Astra, Pfizer boost China bets despite US drive to decouple
freemalaysiatoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freemalaysiatoday.com Daily Mail and Mail on Sunday newspapers.

United kingdomAlbert bourlaPascal soriotUs congressAstrazeneca plcWuxi apptec coAstra to merck coEccogene incPfizer incGracell biotechnologies incBiosecure act

AstraZeneca to buy cancer drug developer for up to $1 2 billion

AstraZeneca to buy cancer drug developer for up to $1 2 billion
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesPascal soriotNovo nordiskEli lilly coAstrazeneca plcGracell biotechnologies incEccogene incGracell biotechnologiesShanghai based gracellEli lillyChief executive officer pascal soriot

AstraZeneca to Buy Cancer Drug Developer for Up to $1 2 Billion

AstraZeneca to Buy Cancer Drug Developer for Up to $1 2 Billion
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNovo nordiskPascal soriotEli lilly coEccogene incBloomberg astrazeneca plcGracell biotechnologies incZeneca plcGracell biotechnologiesShanghai based gracellExperimental cancer cure offers hopeEli lillyChief executive officer pascal soriotFormerjj top scientist bets

AstraZeneca Buys Cancer Drug Developer Gracell for Up to $1 2 Billion

AstraZeneca Buys Cancer Drug Developer Gracell for Up to $1 2 Billion
themiddlemarket.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themiddlemarket.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNovo nordiskPascal soriotAstrazeneca plc nasdaqEccogene incEli lilly coGracell biotechnologies incAstrazeneca plcGracell biotechnologiesShanghai based gracellEli lillyChief executive officer pascal soriot

Investors can t help gorging on anti-obesity drugs

Roche is belatedly buying its way into the booming market for weight-loss treatments, with a $3 billion biotech deal

United statesThomas schineckerEccogene incEli lilly coRoche holdingBarclays plcMorgan stanleyBloomberg intelligenceIndianapolis based eli lillyChief executive officer thomas schineckerCarmot therapeuticsAnti obesity drugs